• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule

Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule

by Scott Wallask | Jul 4, 2024 | Elite, FDA-lca, Lab Industry Advisor

Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: Startup Women’s Health Lab Receives $4M in Federal Grants

Diagnostics Pipeline: Startup Women’s Health Lab Receives $4M in Federal Grants

by Ron Shinkman | Jun 27, 2024 | Clinical Diagnostics Insider, FDA-dtet

The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Removing Racial Inequalities in Lab Referrals

Removing Racial Inequalities in Lab Referrals

by Oscelle Boye, MBiomed | Apr 26, 2024 | Clinical Diagnostics Insider, Testing Trends-dtet

Clinical laboratory professionals must consider how race affects test referrals and what they can do to combat existing inequities

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Diagnostics Pipeline: FDA Approves First Ever Fentanyl Test Strips for OTC Use

The Diagnostics Pipeline: FDA Approves First Ever Fentanyl Test Strips for OTC Use

by Glenn S. Demby | Nov 24, 2023 | Clinical Diagnostics Insider, FDA-dtet

Approval for OTC use of a urine drug test that can be performed by non-CLIA facilities could help expand accessibility, expert says.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A New Tool for Helping Labs Improve Diversity in Clinical Trials

A New Tool for Helping Labs Improve Diversity in Clinical Trials

by Rachel Rangel, AuD | Nov 7, 2023 | Industry Perspectives, Open Content

Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com